گروه دارویی برکت
برکت | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 5,070 1.81
Close Price: 5,050
Cash Flow
AGM
Interim
2026/06/30 Fiscal Year 2026/03/2012 Month / Audited | 2026/06/18 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | -518.272 Billion | 15.565 Trillion | |
Income Taxes Paid | -2.485 Trillion | -2.485 Trillion | |
Net Cash Flow from Operating Activities | 16.314 Trillion | 13.08 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 933.665 Billion | 41.738 Billion | |
Purchases of Property, Plant and Equipment | -16.106 Trillion | -6.839 Trillion | |
Proceeds from Sale of Assets Held for Sale | 128.12 Billion | 128.12 Billion | |
Proceeds from Sale of Intangible Assets | 100 Billion | 100 Billion | |
Purchases of Intangible Assets | -1.099 Trillion | -57.246 Billion | |
Proceeds from Sale of Long-Term Investments | 77.145 Billion | 205.449 Billion | |
Cash Paid to Acquire Long-Term Investments | -72.987 Billion | - | |
Cash Paid for Loans Granted to Others | -2.361 Trillion | -4.696 Trillion | |
Cash Received from Repayment of Loans Granted to Others | 4.162 Trillion | 6.35 Trillion | |
Net Cash Flow from Investing Activities | -14.466 Trillion | -6.65 Trillion | |
Net Cash Flow before Financing Activities | 1.363 Trillion | 6.43 Trillion | |
Cash Received from Capital Increases of Subsidiaries | 5.354 Trillion | 4.388 Trillion | |
Purchases of Treasury Shares | -648.85 Billion | -483.278 Billion | |
Cash Received from Borrowings | 140.82 Trillion | 142.867 Trillion | |
Repayments of Borrowings (Principal) | -105.005 Trillion | -112.79 Trillion | |
Interest Paid on Borrowings | -28.341 Trillion | -23.838 Trillion | |
Dividends Paid | -547.283 Billion | -392.973 Billion | |
Dividends Paid to Non-Controlling Interests | -1.91 Trillion | -8.589 Trillion | |
Other Cash Flows from Financing Activities | 495.043 Billion | 4.474 Trillion | |
Net Cash Flow from Financing Activities | 10.217 Trillion | 95.402 Billion | |
Net Increase (Decrease) in Cash | 12.065 Trillion | 988.123 Billion | |
Cash at Beginning of Period | 7.746 Trillion | 7.746 Trillion | |
Effect of Exchange Rate Changes | -273.016 Billion | 2.866 Billion | |
Cash at End of Period | 7.473 Trillion | 7.473 Trillion | |
Non-Cash Transactions | 17.16 Trillion | 10.029 Trillion |